Want to cut your energy bills? Here’s how five experts are doing it 
John Ternus Signals Apple’s Future with Product-First AI Strategy 
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns 
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch 
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed 
OPmobility Reports Q1 Revenue Dip Amid Automotive Industry Slowdown 
Ethiopian Airlines Expands Fleet with New Boeing 787 Dreamliner Order to Boost Global Routes 
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions 
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook 
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs 
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank 
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals 
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow 
Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions 
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows 
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, March 01, 2017 -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced presentations at the following conferences taking place in March:
37th Annual Cowen & Co. Healthcare Conference, at the Boston Marriott Copley Place, in Boston Massachusetts.
- Matthew Kapusta, chief executive officer, will present on Wednesday, March 8th at 10.00 a.m. EST. The live webcast can be accessed through the link displayed in the Investor section of the uniQure website at: http://uniqure.com/investors-newsroom/events-presentations.php. The webcast replay will be available for at least two weeks following the live event.
Oppenheimer 27th Annual Healthcare Conference, at the Westin New York Grand Central, in New York City.
- Matthew Kapusta, chief executive officer, will participate in a Fireside Chat with analyst Hartaj Singh on Tuesday March 21st at 3.55 p.m. EST. The live webcast can be accessed through the link displayed in the Investor section of the uniQure website at: http://uniqure.com/investors-newsroom/events-presentations.php. The webcast replay will be available for at least two weeks following the live event.
11th Annual Symposium of the Coalition for Hemophilia B, at the Sawgrass Marriott Golf Resort in Ponte Vedra, Florida.
- uniQure will be exhibiting throughout the conference from Friday March 31st to Sunday April 2nd.
About uniQure
uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with hemophilia, Huntington’s disease and cardiovascular diseases. www.uniQure.com
uniQure Contacts: Maria E. Cantor Direct: 339-970-7536 Mobile: 617-680-9452 [email protected] Tom Malone Direct: 339-970-7558 Mobile: 339-223-8541 [email protected] Eva M. Mulder Direct: +31 20 240 6103 Mobile: +31 6 52 33 15 79 [email protected]
